154 related articles for article (PubMed ID: 2814337)
21. Prevention of acute experimental pancreatitis in rats and dogs by intraduodenal infusion of a synthetic trypsin inhibitor.
Takasugi S; Yonezawa H; Ikei N; Kanno T
Digestion; 1982; 24(1):36-41. PubMed ID: 6182046
[No Abstract] [Full Text] [Related]
22. A somatostatin analogue is protective against retrograde bile salt-induced pancreatitis in the rat.
Zhu ZH; Holt S; el-Lbishi MS; Grady T; Taylor TV; Powers RE
Pancreas; 1991 Sep; 6(5):609-13. PubMed ID: 1719527
[TBL] [Abstract][Full Text] [Related]
23. Effects of urinary trypsin inhibitor on pancreatic enzymes and experimental acute pancreatitis.
Ohnishi H; Kosuzume H; Ashida Y; Kato K; Honjo I
Dig Dis Sci; 1984 Jan; 29(1):26-32. PubMed ID: 6363018
[TBL] [Abstract][Full Text] [Related]
24. The time course of ultrastructural changes in the secretory components of pancreatic acinar cells and trypsinogen activation in taurocholate pancreatitis in rats.
Andrzejewska A; Długosz JW; Szynaka B
Rocz Akad Med Bialymst; 1996; 41(2):363-73. PubMed ID: 9020548
[TBL] [Abstract][Full Text] [Related]
25. Effects of pancreatic duct ligation and aging on acute taurocholate-induced pancreatitis. Experiments in the perfused pancreas in rats.
Kimura W; Okubo K; Han I; Kanai S; Matsushita A; Muto T; Miyasaka K
Int J Pancreatol; 1996 Apr; 19(2):117-27. PubMed ID: 8723554
[TBL] [Abstract][Full Text] [Related]
26. Correlation between serum concentrations of three specific exocrine pancreatic proteins and pancreatic duct morphology at ERCP examinations.
Borgström A; Wehlin L
Scand J Gastroenterol; 1984 Mar; 19(2):220-7. PubMed ID: 6201996
[TBL] [Abstract][Full Text] [Related]
27. Experimental pancreatitis in the rat. Development of pancreatic necrosis, ischemia and edema after intraductal sodium taurocholate injection.
Aho HJ; Nevalainen TJ; Aho AJ
Eur Surg Res; 1983; 15(1):28-36. PubMed ID: 6840152
[TBL] [Abstract][Full Text] [Related]
28. Neutrophil Extracellular Traps Induce Trypsin Activation, Inflammation, and Tissue Damage in Mice With Severe Acute Pancreatitis.
Merza M; Hartman H; Rahman M; Hwaiz R; Zhang E; Renström E; Luo L; Mörgelin M; Regner S; Thorlacius H
Gastroenterology; 2015 Dec; 149(7):1920-1931.e8. PubMed ID: 26302488
[TBL] [Abstract][Full Text] [Related]
29. Effect of a specific synthetic inhibitor of neutrophil elastase (ONO-5046) on the course of acute hemorrhagic pancreatitis in dogs.
Imamura M; Mikami Y; Takahashi H; Yamauchi H
J Hepatobiliary Pancreat Surg; 1998; 5(4):422-8. PubMed ID: 9931392
[TBL] [Abstract][Full Text] [Related]
30. Experimental pancreatitis in the rat. Ductal factors in sodium taurocholate-induced acute pancreatitis.
Aho HJ; Suonpää K; Ahola RA; Nevalainen TJ
Exp Pathol; 1984; 25(2):73-9. PubMed ID: 6539232
[TBL] [Abstract][Full Text] [Related]
31. Pancreatic secretory trypsin inhibitor I reduces the severity of chronic pancreatitis in mice overexpressing interleukin-1β in the pancreas.
Romac JM; Shahid RA; Choi SS; Karaca GF; Westphalen CB; Wang TC; Liddle RA
Am J Physiol Gastrointest Liver Physiol; 2012 Mar; 302(5):G535-41. PubMed ID: 22173919
[TBL] [Abstract][Full Text] [Related]
32. Glucagon treatment of experimental acute pancreatitis.
Papp M; Ribet A; Fodor I; Németh PE; Fehér S; Horváth JE; Folly G
Acta Med Acad Sci Hung; 1975; 32(2):105-16. PubMed ID: 1235217
[TBL] [Abstract][Full Text] [Related]
33. Effect of a new synthetic trypsin inhibitor on taurocholate-induced acute pancreatitis in rats.
Sobajima H; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Sakai Y; Ishiguro H; Tanikawa M; Nakae Y
Pancreas; 1993 Mar; 8(2):240-7. PubMed ID: 8460097
[TBL] [Abstract][Full Text] [Related]
34. Pathological events in experimental acute pancreatitis prevented by the bradykinin antagonist, Hoe 140.
Griesbacher T; Tiran B; Lembeck F
Br J Pharmacol; 1993 Feb; 108(2):405-11. PubMed ID: 8448591
[TBL] [Abstract][Full Text] [Related]
35. Immunoreactive trypsins in sera from dogs before and after induction of experimental pancreatitis.
Borgström A; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1980 May; 361(5):625-31. PubMed ID: 6159294
[TBL] [Abstract][Full Text] [Related]
36. On the role of the pancreatic secretory trypsin inhibitor as an inactivator of trypsin-alpha 2-macroglobulin complexes in acute pancreatitis.
Balldin G; Borgström A; Marks WH; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1984 Jul; 365(7):751-6. PubMed ID: 6207093
[TBL] [Abstract][Full Text] [Related]
37. Trypsinogen activation and glutathione content are linked to pancreatic injury in models of biliary acute pancreatitis.
Lüthen R; Grendell JH; Niederau C; Häussinger D
Int J Pancreatol; 1998 Dec; 24(3):193-202. PubMed ID: 9873954
[TBL] [Abstract][Full Text] [Related]
38. THE ROLE OF PANCREATIC ENZYMES IN THE PATHOGENESIS OF ACUTE PANCREATITIS. III. COMPARISON OF THE PATHOLOGIC AND BIOCHEMICAL CHANGES IN THE CANINE PANCREAS TO INTRADUCTAL INJECTION WITH BILE AND WITH TRYPSIN.
BECK IT; KAHN DS; SOLYMAR J; MCKENNA RD; ZYLBERSZAC B
Gastroenterology; 1964 May; 46():531-42. PubMed ID: 14153962
[No Abstract] [Full Text] [Related]
39. A radioimmunoassay for measurement of human pancreatic secretory trypsin inhibitor in different body fluids.
Eddeland A; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1978 Jun; 359(6):671-5. PubMed ID: 669578
[TBL] [Abstract][Full Text] [Related]
40. [Effects of E-3123, a new protease inhibitor, on several protease activities and on experimental acute pancreatitis].
Miyamoto K; Hishinuma I; Nagakawa J; Nagaoka N; Yamanaka T; Wakabayashi T
Nihon Yakurigaku Zasshi; 1988 May; 91(5):285-93. PubMed ID: 3410375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
